Eslicarbazepine acetate in the management of refractory bipolar disorder

Kamal Nath; Arnab Bhattacharya; Samir Kumar Praharaj

doi:10.1097/WNF.0b013e318271220b

Eslicarbazepine acetate in the management of refractory bipolar disorder

Kamal Nath
, Arnab Bhattacharya
, Samir Kumar Praharaj^*

^*Corresponding author for this work

Department of Psychiatry, Kasturba Medical College, Manipal

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

Original language	English
Pages (from-to)	295
Number of pages	1
Journal	Clinical Neuropharmacology
Volume	35
Issue number	6
DOIs	https://doi.org/10.1097/WNF.0b013e318271220b
Publication status	Published - 01-11-2012

All Science Journal Classification (ASJC) codes

Pharmacology
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1097/WNF.0b013e318271220b

Cite this

@article{c6d48262c3ac49cab373caa3544f6931,

title = "Eslicarbazepine acetate in the management of refractory bipolar disorder",

abstract = "Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.",

author = "Kamal Nath and Arnab Bhattacharya and Praharaj, \{Samir Kumar\}",

year = "2012",

month = nov,

day = "1",

doi = "10.1097/WNF.0b013e318271220b",

language = "English",

volume = "35",

pages = "295",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Eslicarbazepine acetate in the management of refractory bipolar disorder

AU - Nath, Kamal

AU - Bhattacharya, Arnab

AU - Praharaj, Samir Kumar

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

AB - Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

UR - https://www.scopus.com/pages/publications/84870015852

UR - https://www.scopus.com/pages/publications/84870015852#tab=citedBy

U2 - 10.1097/WNF.0b013e318271220b

DO - 10.1097/WNF.0b013e318271220b

M3 - Article

C2 - 23151469

AN - SCOPUS:84870015852

SN - 0362-5664

VL - 35

SP - 295

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 6

ER -

Eslicarbazepine acetate in the management of refractory bipolar disorder

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this